TRAK:NYSEReposiTrak, Inc. Analysis
Data as of 2026-05-27 - not real-time
$10.32
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
ReposiTrak, Inc. (TRAK) is trading at roughly $10.32 with a price-to-earnings multiple of 28, well below the software‑application industry average of 40, indicating relative valuation comfort. Operating margins of 38% and a profit margin above 30% demonstrate strong profitability despite flat revenue growth. The balance sheet is solid, with cash exceeding $26 million and minimal debt, supporting a sustainable dividend yield of 0.79% and a low payout ratio. Technical indicators show the 20‑day SMA sitting above the 50‑day SMA, a bullish MACD crossover, and an RSI in the low‑to‑mid 60s, suggesting modest upside momentum without immediate overbought pressure. However, volume trends are decreasing and 30‑day volatility is high at roughly 66%, flagging short‑term liquidity concerns. The DCF model values the stock near $5.30, implying the market price may be stretched, yet the lower PE relative to peers tempers the overvaluation view. Recent earnings calls highlighted a successful transition to a pure SaaS model and improved cash conversion, reinforcing confidence in the business model. The company’s strategic partnership with Upshop enhances its traceability offering, a growth avenue in the regulated grocery sector. Overall, the stock sits at a technical support level near $8.65, providing a cushion against downside, while the consensus analyst recommendation remains a "buy".
Given the blend of solid fundamentals, modest technical strength, and a dividend that appears sustainable, TRAK presents a balanced risk‑reward profile for investors willing to tolerate higher volatility in exchange for potential upside tied to SaaS adoption and margin expansion.
Given the blend of solid fundamentals, modest technical strength, and a dividend that appears sustainable, TRAK presents a balanced risk‑reward profile for investors willing to tolerate higher volatility in exchange for potential upside tied to SaaS adoption and margin expansion.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover
- RSI in a comfortable range
- Support level provides downside buffer
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong operating and profit margins
- SaaS transition driving cash flow stability
- Analyst upside potential exceeding 50%
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend with low payout ratio
- Flat revenue growth raises growth sustainability questions
- High volatility and decreasing volume may limit price appreciation
Key Metrics & Analysis
Financial Health
Revenue Growth-0.50%
Profit Margin31.05%
P/E Ratio27.9
ROE14.66%
ROA8.41%
Debt/Equity0.69
P/B Ratio3.8
Op. Cash Flow$7.5M
Free Cash Flow$5.3M
Industry P/E40.4
Technical Analysis
TrendNeutral
RSI63.7
Support$8.65
Resistance$10.54
MA 20$9.79
MA 50$8.59
MA 200$12.21
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$5.29
Target Price$16.00
Upside/Downside55.04%
GradeFair
TypeBlend
Dividend Yield0.79%
Risk Assessment
Beta1.07
Volatility65.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.